A

Aquestive Therapeutics
D

AQST

2.99000
USD
0.01
(0.17%)
مغلق
حجم التداول
25,216
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
295,625,393
أصول ذات صلة
A
ACRE
0.06500
(1.60%)
4.13500 USD
A
ADMA
0.240
(1.03%)
23.510 USD
ALNY
ALNY
3.98
(1.56%)
259.33 USD
A
ANIP
2.280
(3.22%)
72.980 USD
A
ARWR
0.380
(2.71%)
14.410 USD
A
AXSM
-0.050
(-0.04%)
112.190 USD
B
BCRX
0.21000
(2.41%)
8.91000 USD
B
BHC
0.11500
(2.17%)
5.41500 USD
C
CRBP
0.26000
(3.45%)
7.79000 USD
المزيد
الأخبار المقالات

العنوان: Aquestive Therapeutics

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.